Ahmed Salman, Mothi Suraj Sarvode, Sequist Thomas, Tangri Navdeep, Khinkar Roaa M, Mendu Mallika L
Division of Renal Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Kidney Med. 2021 Oct 15;4(1):100375. doi: 10.1016/j.xkme.2021.08.010. eCollection 2022 Jan.
RATIONALE & OBJECTIVE: The 4-variable kidney failure risk equation (KFRE) allows for the prediction of chronic kidney disease (CKD) progression using age, sex, estimated glomerular filtration rate, and urine albumin/creatinine ratio. Electronic health records enable KFRE auto-calculation, and registries allow population-level application. We assessed whether 2-year KFRE score categories are associated with CKD care metrics.
Cross-sectional cohort.
SETTING & PARTICIPANTS: This study included individuals with CKD in March 2020 who were receiving care within the Partners HealthCare system in Massachusetts.
The presence of sufficient data to calculate the KFRE and, among those with a KFRE score, performance on CKD clinical care metrics, including (1) prescription of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker; (2) blood pressure at goal (<140/90 mm Hg) based on clinic measurements; (3) composite metric of hepatitis B virus immunity; (4) composite metric of referral, evaluation, or waitlist status for kidney transplantation; (5) advance directive documentation; (6) yearly influenza vaccination; and (7) pneumonia vaccination.
Multivariable logistic regression analysis was used to analyze the association of KFRE score category with CKD care metrics.
Of 61,546 patients, 18,272 (30%) had auto-calculated 2-year KFRE scores; the remaining patients lacked KFRE scores because of absent albuminuria assessment. Individuals with a KFRE score were more likely to have a primary care provider or nephrologist. Among patients with 2-year KFRE scores, high-risk patients had increased odds of completing advance directives (OR, 1.52; 95% CI, 1.07-2.17), while low-risk patients had decreased odds of influenza vaccination (OR, 0.85; 95% CI, 0.75-0.97). Patients with moderate- and high-risk KFRE scores had lower odds of having blood pressure at goal (OR, 0.77; 95% CI, 0.61-0.96 and OR, 0.63; 95% CI, 0.44-0.88, respectively).
Albuminuria data may have been assessed outside of the Partners system.
A higher-risk KFRE score is associated with the delivery of some but not all CKD care measures. An opportunity exists to improve albuminuria measurement.
四变量肾衰竭风险方程(KFRE)可通过年龄、性别、估算肾小球滤过率和尿白蛋白/肌酐比值来预测慢性肾脏病(CKD)的进展。电子健康记录可实现KFRE的自动计算,而登记系统则允许在人群层面应用。我们评估了2年KFRE评分类别与CKD护理指标之间是否存在关联。
横断面队列研究。
本研究纳入了2020年3月在马萨诸塞州合作伙伴医疗系统内接受治疗的CKD患者。
有足够数据计算KFRE,以及在有KFRE评分的患者中,CKD临床护理指标的表现,包括(1)血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂的处方;(2)根据诊所测量结果,血压达标(<140/90 mmHg);(3)乙肝病毒免疫综合指标;(4)肾脏移植转诊、评估或等待名单状态的综合指标;(5)预先指示文件;(6)年度流感疫苗接种;(7)肺炎疫苗接种。
采用多变量逻辑回归分析来分析KFRE评分类别与CKD护理指标之间的关联。
在61546例患者中,18272例(30%)自动计算出了2年KFRE评分;其余患者因未进行蛋白尿评估而缺乏KFRE评分。有KFRE评分的个体更有可能有初级保健医生或肾病专家。在有2年KFRE评分的患者中,高危患者完成预先指示的几率增加(OR,1.52;95%CI,1.07 - 2.17),而低危患者接种流感疫苗的几率降低(OR,0.85;95%CI,0.75 - 0.97)。中度和高危KFRE评分的患者血压达标的几率较低(OR分别为0.77;95%CI,0.61 - 0.96和OR,0.63;95%CI,0.44 - 0.88)。
蛋白尿数据可能是在合作伙伴系统之外评估的。
较高风险的KFRE评分与部分而非全部CKD护理措施的实施相关。存在改善蛋白尿测量的机会。